Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 2
- Adult 3
- Aged 1
- Aged, 80 and over 1
- Antiviral Agents 4
- Article 1
- Child 1
- Child, Preschool 1
- Correction 1
- Dispatch 3
- Drug Resistance, Viral 4
- Enzyme Inhibitors 1
- Epidemiological Monitoring 1
- Female 3
- Humans 4
- Immunocompromised Host 1
- Infant 1
- Influenza, Human 2
- Influenza, Human/drug therapy 1
- Influenza, Human/epidemiology 1
- Influenza, Human/mortality 1
- Influenza, Human/virology 1
- Influenza A Virus, H1N1 Subtype 3
- Male 3
- Microbial Sensitivity Tests 1
- Middle Aged 2
- Neuraminidase 3
- Orthomyxoviridae 1
- Oseltamivir 5
- pandemic H1N1 1
- Pandemics 2
- peramivir 1
- Phylogeny 1
- Population Surveillance 1
- Prevalence 2
- seasonal influenza A and B 1
- Viral Proteins 2
- Young Adult 2
- Zanamivir 1
- zanamivir 1
Personal Author
Corporate Author
Place as Subject
Resource Type General
Select all docs (Max 200)
1 -
6 of 6 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (2)
- Adult (3)
- Aged (1)
- Aged, 80 and over (1)
- Antiviral Agents (4)
- Article (1)
- Child (1)
- Child, Preschool (1)
- Correction (1)
- Dispatch (3)
- Drug Resistance, Viral (4)
- Enzyme Inhibitors (1)
- Epidemiological Monitoring (1)
- Female (3)
- Humans (4)
- Immunocompromised Host (1)
- Infant (1)
- Influenza, Human (2)
- Influenza, Human/drug therapy (1)
- Influenza, Human/epidemiology (1)
- Influenza, Human/mortality (1)
- Influenza, Human/virology (1)
- Influenza A Virus, H1N1 Subtype (3)
- Male (3)
- Microbial Sensitivity Tests (1)
- Middle Aged (2)
- Neuraminidase (3)
- Orthomyxoviridae (1)
- Oseltamivir (5)
- pandemic H1N1 (1)
- Pandemics (2)
- peramivir (1)
- Phylogeny (1)
- Population Surveillance (1)
- Prevalence (2)
- seasonal influenza A and B (1)
- Viral Proteins (2)
- Young Adult (2)
- Zanamivir (1)
- zanamivir (1)
- :Okomo-Adhiambo, Margaret ;Sleeman, KatrinaOctober 13 2010 | Viruses. 2010; 2(10):2269-2289:Neuraminidase inhibitors (NAIs) are vital in managing seasonal and pandemic influenza infections. NAI susceptibilities of virus isolates (n = 5540) co...
- :Okomo-Adhiambo, Margaret ;Sleeman, KatrinaAugust 12 2011 | Viruses. 2011; 3(8):1415-1416
- :Okomo-Adhiambo, Margaret ;Nguyen, Ha TDecember 02 2013 | Influenza Other Respir Viruses. 2013; 8(2):258-265:BackgroundAssessing susceptibility of influenza viruses to neuraminidase (NA) inhibitors (NAIs) is primarily done in NA inhibition (NI) assays, supple...
- :Graitcer, Samuel B. ;Gubareva, LarisaFeb 2011 | Emerg Infect Dis. 17(2):255-257.:During April 2009-June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistan...
- :Storms, Aaron D. ;Gubareva, Larisa V.Feb 2012 | Emerg Infect Dis. 18(2):308-311.:During October 2010-July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 200...
- :Okomo-Adhiambo, Margaret ;Fry, Alicia M.Jan 2015 | Emerg Infect Dis. 21(1):136-141.:We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States. Durin...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.